Top Biotechnology companies in United States by Total Liabilities

This ranking features the top 509 Biotechnology companies in United States ranked by Total Liabilities, totaling a Total Liabilities of USD 911.27 B, for June 26, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBIT EBITDA Net Income Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

1 2 3 4 … 11

Frequently Asked Questions

Which Biotechnology company in United States has the highest Total Liabilities ?

The Biotechnology company in United States with the highest Total Liabilities is AbbVie Inc. (NYSE: ABBV) at USD 131.80 B.
Which Biotechnology company in United States has the lowest Total Liabilities ?

The Biotechnology company in United States with the lowest Total Liabilities is Annexon, Inc. (NasdaqGS: ANNX) at None.

What are the top 10 Biotechnology companies in United States by Total Liabilities ?

The top 10 Biotechnology companies in United States by Total Liabilities are AbbVie Inc., Pfizer Inc., Amgen Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Thermo Fisher Scientific Inc., Gilead Sciences, Inc., Abbott Laboratories, Becton, Dickinson and Company and Danaher Corporation.
What are the bottom 10 Biotechnology companies in United States by Total Liabilities ?

The bottom 10 Biotechnology companies in United States by Total Liabilities are Annexon, Inc., Alto Neuroscience, Inc., Anebulo Pharmaceuticals, Inc., Autonomix Medical, Inc. Common Stock, Alzamend Neuro, Inc., Anixa Biosciences, Inc., Aclaris Therapeutics, Inc., Actuate Therapeutics Inc, Aclarion, Inc. and AN2 Therapeutics, Inc..